Drugs Containing Excipient (Inactive Ingredient) CETEARYL ALCOHOL

« Back to Dashboard

Generic drugs containing CETEARYL ALCOHOL excipient

Company	Ingredient	NDC	Excipient
A-S Medication Solutions	clotrimazole	50090-0614	CETEARYL ALCOHOL
A-S Medication Solutions	clotrimazole and betamethasone dipropionate	50090-4876	CETEARYL ALCOHOL
A-S Medication Solutions	clotrimazole	50090-7343	CETEARYL ALCOHOL
A-S Medication Solutions	clotrimazole	50090-7376	CETEARYL ALCOHOL

Cetearyl Alcohol Market Dynamics, Pricing, Applications, and Financial Trajectory

Last updated: September 24, 2026

Cetearyl alcohol is a high-volume fatty alcohol excipient used as a consistency agent, co-emulsifier, thickener, emollient, and stabilizer in topical pharmaceuticals, dermatology products, cosmetics, and personal-care formulations. Its financial trajectory is tied less to pharmaceutical demand alone than to the broader market for creams, lotions, ointments, conditioners, and emulsions.

Standalone global revenue for cetearyl alcohol is not generally disclosed by manufacturers. Public company filings report broader specialty chemicals or personal-care ingredient revenue rather than product-level sales. The market is therefore best assessed through end-use demand, fatty-alcohol feedstock costs, regional manufacturing capacity, regulatory requirements, and formulation switching costs.

Cetearyl alcohol has limited patent value as a chemical substance. Commercial protection comes from supply qualification, pharmacopeial quality, manufacturing consistency, sustainability certifications, and formulation know-how. It has no Orange Book exclusivity, no biosimilar exposure, and no conventional Paragraph IV risk.

What is cetearyl alcohol and how is it used in pharmaceuticals?

Cetearyl alcohol is a mixture of long-chain fatty alcohols, principally cetyl alcohol and stearyl alcohol. Commercial grades vary in the ratio of the two components, purity, melting range, acid value, hydroxyl value, and residual impurities.

Attribute	Commercial description
Common names	Cetearyl alcohol, cetostearyl alcohol, cetyl-stearyl alcohol
Typical CAS reference	67762-27-0 for cetearyl alcohol mixtures
Chemical class	Long-chain fatty alcohol mixture
Primary components	Cetyl alcohol and stearyl alcohol
Physical form	White waxy solid or flakes
Pharmaceutical role	Thickener, emollient, co-emulsifier, consistency agent
Common dosage forms	Creams, lotions, ointments, gels, emulsions
Route of administration	Primarily topical and dermatological
Regulatory category	Inactive excipient rather than active pharmaceutical ingredient

Cetearyl alcohol improves viscosity and emulsion stability. It can create a structured internal phase in oil-in-water and water-in-oil systems. Formulators often combine it with surfactants such as ceteareth-20, polysorbates, glyceryl stearate, or sodium lauryl sulfate.

In topical formulations, cetearyl alcohol can also improve spreadability and skin feel. It is not the same as ethanol and does not have the drying or antiseptic profile associated with low-molecular-weight alcohols.

How large is the cetearyl alcohol market?

The market is fragmented across pharmaceutical excipients, cosmetic ingredients, personal-care chemicals, and industrial fatty alcohols. Public market reports frequently combine cetearyl alcohol with cetyl alcohol, stearyl alcohol, fatty alcohols, emulsifiers, or cosmetic ingredients. Those categories are not interchangeable and produce materially different revenue estimates.

A defensible market assessment uses three layers:

1. The broad fatty-alcohol market, which supplies the raw materials.
2. The specialty personal-care and pharmaceutical excipient market, which determines grade premiums.
3. Cetearyl alcohol product sales, which are rarely reported separately.

The market is supported by recurring demand from:

• Generic dermatology products
• Prescription and nonprescription creams
• Moisturizers and barrier-repair products
• Sunscreens
• Hair conditioners
• Skin cleansers
• Compounded topical preparations
• Veterinary creams and ointments

Pharmaceutical demand is relatively stable because cetearyl alcohol is a mature excipient with extensive formulation history. The faster growth generally comes from topical drug delivery, dermocosmetics, premium skin care, and products marketed around barrier protection.

What factors are driving cetearyl alcohol demand?

Growth in topical pharmaceutical products

Topical formulations require excipients that provide viscosity, stability, sensory performance, and manufacturing robustness. Cetearyl alcohol remains attractive because it performs several functions in one ingredient and is compatible with common pharmaceutical oils, surfactants, preservatives, and active ingredients.

Demand benefits from the expansion of topical generics and consumer self-care products. Dermatology products for atopic dermatitis, psoriasis, acne, fungal infections, wounds, and dry skin frequently use fatty alcohols in cream or lotion bases.

Expansion of skin-care and dermocosmetic products

The largest demand pool is broader than prescription pharmaceuticals. Skin-care products use cetearyl alcohol in moisturizers, cleansers, masks, sunscreens, and anti-aging formulations. Cosmetic and personal-care demand can offset slower pharmaceutical volume growth.

The ingredient is also used in “natural,” plant-derived, and vegan-positioned products when the source and processing route meet the brand’s claims. This creates a commercial premium for traceable feedstocks, although the chemical identity does not by itself establish a natural or sustainable origin.

Substitution limits

Cetearyl alcohol can be replaced by cetyl alcohol, stearyl alcohol, behenyl alcohol, glyceryl stearate, hydrogenated vegetable oils, waxes, or synthetic rheology modifiers. Substitution is possible, but it can alter:

• Emulsion stability
• Viscosity
• Melting behavior
• Spreadability
• Absorption
• Sensory profile
• Preservative performance
• Manufacturing temperature
• Finished-product appearance

These formulation effects create moderate switching costs. A manufacturer can change suppliers more easily than it can change the excipient system without conducting comparative development and stability work.

How do raw-material prices affect cetearyl alcohol margins?

Cetearyl alcohol economics are driven primarily by fatty-acid and fatty-alcohol feedstocks. The main cost variables include palm oil, palm kernel oil, coconut oil, tallow, oleochemical intermediates, energy, hydrogen, freight, and packaging.

The product can be manufactured from plant-based or animal-derived feedstocks. Palm and palm-kernel supply chains are particularly important for oleochemical production. Price volatility can result from:

• Weather and crop yields
• Biodiesel policy
• Palm-oil export restrictions
• Energy prices
• Shipping costs
• Currency movements
• Regional supply disruptions
• Sustainability certification requirements

Manufacturers with integrated oleochemical operations typically have greater control over feedstock sourcing and conversion economics. Distributors and toll formulators have less protection from raw-material volatility.

Pharmaceutical grades usually command a premium over industrial material because buyers may require tighter specifications, pharmacopeial compliance, audit access, change-control procedures, lot traceability, and documentation packages. The premium is generally more defensible when the supplier provides USP-NF, Ph. Eur., or equivalent compliance and maintains validated manufacturing controls.

Which companies supply cetearyl alcohol?

The supplier base includes integrated oleochemical producers, specialty ingredient manufacturers, pharmaceutical excipient distributors, and regional chemical companies. Relevant commercial participants include:

Company or group	Market position
BASF	Personal-care and pharmaceutical ingredient supplier with fatty-alcohol and emulsifier products
Croda	Specialty excipient and personal-care ingredient supplier
KLK OLEO	Integrated oleochemical producer with fatty alcohol capacity
Emery Oleochemicals	Oleochemical manufacturer serving personal care and pharmaceutical markets
VVF	Fatty alcohol and oleochemical producer
Kao Chemicals	Oleochemical and specialty ingredient supplier
IOI Oleo	Integrated producer of oleochemical derivatives
AAK	Vegetable-oil and specialty lipid supplier with formulation exposure
Regional distributors	Supply pharmaceutical and cosmetic grades to local formulators

The competitive market is based on qualification, consistency, lead time, documentation, and total delivered cost. Product identity alone rarely differentiates suppliers.

Public filings from major ingredient companies generally group cetearyl alcohol within broader personal-care, life-science, oleochemical, or specialty-chemical portfolios. They do not normally disclose standalone cetearyl alcohol revenue or margin. [1-4]

What formulations are protected by cetearyl alcohol?

Cetearyl alcohol itself is an established excipient and is not generally protected by an active compound patent. Patent protection may apply to a finished formulation that contains cetearyl alcohol, particularly when the formulation claims a specific combination of:

• Active pharmaceutical ingredient
• Oil phase
• Surfactant system
• Cetearyl alcohol concentration
• Particle size or droplet size
• pH range
• Preservative system
• Release profile
• Manufacturing sequence
• Therapeutic use

Formulation patents can remain relevant after the active ingredient’s basic compound patent expires. Their strength depends on claim breadth, written-description support, enablement, prosecution history, validity defenses, and the availability of non-infringing alternatives.

A formulation patent that merely lists cetearyl alcohol among many possible excipients may provide limited practical protection. A patent requiring a narrow concentration range or a defined emulsifier ratio may create a stronger design-around barrier if the formulation’s performance depends on that combination.

What is the FDA regulatory status of cetearyl alcohol?

Cetearyl alcohol is used as an inactive ingredient in FDA-regulated drug products, particularly topical dosage forms. The FDA Inactive Ingredient Database is the principal public reference for prior use in approved drug products and dosage forms. [5]

FDA status depends on the exact substance name, route, dosage form, concentration, and product context. A prior inactive-ingredient listing does not automatically authorize every concentration or every route. Sponsors must still establish identity, quality, safety, suitability, and compatibility within the finished product.

Cetearyl alcohol is also covered by recognized pharmacopeial standards where the applicable grade complies with the relevant monograph. Buyers commonly assess:

• Identification
• Assay or composition
• Hydroxyl value
• Acid value
• Iodine value
• Saponification value
• Melting range
• Residual solvents
• Elemental impurities
• Microbial quality
• Animal-origin status
• Allergen and contaminant controls

The European Union regulates cosmetic use through the EU Cosmetics Regulation and associated ingredient database, while pharmaceutical use depends on the finished product’s regulatory pathway and applicable European Pharmacopoeia requirements. [6]

Does cetearyl alcohol have Orange Book patents or exclusivity?

No. Cetearyl alcohol is an excipient, not an FDA-approved active pharmaceutical ingredient with drug-specific Orange Book exclusivity.

Regulatory issue	Cetearyl alcohol position
Orange Book listing	No standalone listing
New chemical entity exclusivity	Not applicable
Pediatric exclusivity	Not applicable to the excipient
Orphan-drug exclusivity	Not applicable to the excipient
Paragraph IV challenge	No standalone excipient challenge
Biosimilar interchangeability	Not applicable
Drug master file strategy	Possible for supplier manufacturing and quality information
Formulation patent risk	Possible in finished products
Method-of-use patent risk	Possible when tied to a drug product or treatment

A generic drug sponsor may face patent litigation involving a cream or ointment that contains cetearyl alcohol. The dispute would ordinarily concern the active ingredient, formulation, manufacturing process, or method of treatment, not ownership of cetearyl alcohol as such.

When does cetearyl alcohol lose exclusivity?

Cetearyl alcohol has no single exclusivity expiration date. It is a mature chemical mixture sold by multiple suppliers. Patent protection for the substance is not the primary commercial control mechanism.

The relevant commercial events are:

• Supplier qualification
• Pharmacopeial compliance
• Regulatory documentation
• Customer-specific specifications
• Sustainability certification
• Manufacturing-site approval
• Contract terms
• Formulation know-how

A supplier can lose a customer when a competing producer offers equivalent quality, lower cost, shorter lead time, or stronger sustainability credentials. Conversely, a qualified supplier can retain share because pharmaceutical customers avoid unnecessary excipient changes that trigger comparative testing, stability work, regulatory review, and supply-chain requalification.

How strong is the intellectual-property position for cetearyl alcohol?

The standalone IP position is weak because the ingredient is old, widely known, and available from numerous producers. Commercial defensibility is stronger at the process, grade, formulation, and supply-chain levels.

Stronger protection areas

• Proprietary purification processes
• Feedstock integration
• Narrow pharmaceutical specifications
• Low-impurity grades
• Certified animal-free or palm-free grades
• Sustainable sourcing systems
• Controlled particle or flake morphology
• Customer-specific blends
• Finished-product formulations
• Manufacturing methods for emulsified dosage forms

Weaker protection areas

• Broad claims to cetearyl alcohol in creams
• Generic use as a thickener or emollient
• Lists of optional excipients
• Basic cosmetic compositions with broad concentration ranges
• Claims that do not require a specific technical effect

The main barrier is qualification and performance reproducibility rather than patent exclusion.

What generic launch risks exist for drugs containing cetearyl alcohol?

Cetearyl alcohol creates limited standalone generic-entry risk. It is widely available and can usually be sourced from multiple qualified manufacturers. Generic entry risk is higher when:

• The reference product depends on a narrow emulsion structure
• The formulation patent requires a specific fatty-alcohol system
• The product has a complex topical delivery profile
• The supplier is single-sourced
• The excipient grade has unusual impurity limits
• The formulation has difficult stability or preservative requirements
• The applicant must demonstrate pharmaceutical equivalence and comparable performance

For conventional creams and ointments, the principal risks usually involve formulation equivalence, manufacturing reproducibility, and patent claims directed to the active product. Cetearyl alcohol itself is rarely the decisive barrier.

How does cetearyl alcohol compare with cetyl alcohol and stearyl alcohol?

Property	Cetearyl alcohol	Cetyl alcohol	Stearyl alcohol
Composition	Mixture of cetyl and stearyl alcohols	Predominantly C16 alcohol	Predominantly C18 alcohol
Texture	Balanced waxy consistency	Softer and more emollient in many systems	Firmer and higher-melting
Formulation role	Thickener and co-emulsifier	Emollient and consistency agent	Stiffener and consistency agent
Typical use	Creams, lotions, conditioners	Creams, lotions, ointments	Ointments, creams, waxy systems
Supply flexibility	Broad	Broad	Broad
Switching impact	Moderate	Can alter texture and viscosity	Can increase stiffness and melting point

Cetearyl alcohol is often selected because the mixture provides a practical balance between structure, spreadability, and emulsion stability. Replacing it with a single fatty alcohol may require adjustment of surfactant ratios, oil-phase composition, process temperature, and concentration.

What is the financial trajectory for cetearyl alcohol?

The medium-term financial trajectory is stable to moderately positive, with growth concentrated in higher-value grades and specialty applications rather than commodity volume alone.

Base-case outlook

• Core pharmaceutical demand: stable
• Topical dermatology demand: positive
• Cosmetic and dermocosmetic demand: positive
• Commodity pricing: cyclical
• Pharmaceutical-grade pricing: more resilient
• Supplier margins: dependent on feedstock integration
• Growth regions: Asia-Pacific, Latin America, and selected Middle Eastern markets
• Mature regions: North America and Europe, with emphasis on premium grades and compliance

Revenue growth is likely to come from volume expansion in topical products, price pass-through during feedstock inflation, and migration toward traceable or certified grades. Margin expansion is less certain because cetearyl alcohol remains substitutable and faces competition from other fatty alcohols and emulsifying systems.

The strongest commercial position belongs to suppliers that combine oleochemical production with pharmaceutical documentation, regional inventory, technical service, and validated change control.

Key Takeaways

• Cetearyl alcohol is a mature, widely used excipient for creams, lotions, ointments, and emulsions.
• Its largest demand base is the combined pharmaceutical, cosmetic, and personal-care market.
• Standalone product revenue is generally not disclosed by public companies.
• Financial performance depends heavily on palm, coconut, tallow, energy, freight, and oleochemical feedstock costs.
• Pharmaceutical-grade products command premiums for compliance, consistency, traceability, and documentation.
• Cetearyl alcohol has no standalone Orange Book exclusivity, NCE exclusivity, biosimilar exposure, or Paragraph IV pathway.
• Patent value lies primarily in finished formulations, manufacturing methods, and specialized grades.
• Generic drug entry is usually constrained by formulation and active-ingredient patents, not access to cetearyl alcohol.
• Supplier qualification and manufacturing consistency are more important commercial barriers than molecule-level IP.
• The market outlook is stable to moderately positive, with the best economics in specialty and certified grades.

FAQs

Is cetearyl alcohol safe for pharmaceutical use?

Cetearyl alcohol is widely used as an inactive ingredient in topical pharmaceutical and cosmetic products. Safety depends on product concentration, route, formulation, impurity profile, and the applicable regulatory assessment.

Is cetearyl alcohol the same as emulsifying wax?

No. Cetearyl alcohol is a fatty alcohol mixture. Emulsifying wax usually contains a fatty alcohol combined with an emulsifier, such as a ceteareth or quaternary surfactant. Commercial emulsifying-wax compositions vary.

Is cetearyl alcohol derived from petroleum?

It can be produced from plant oils, animal fats, or synthetic feedstocks. The commercial source depends on the manufacturer and grade. Feedstock origin must be confirmed through supplier documentation.

Can cetearyl alcohol be used in sterile pharmaceutical products?

It can be an excipient in certain products, but suitability depends on the dosage form, sterilization process, microbial controls, and regulatory requirements. It is more commonly associated with nonsterile topical formulations.

Does cetearyl alcohol create a supply-chain risk for drug manufacturers?

Usually, the risk is manageable because multiple global suppliers produce fatty alcohols and cetearyl alcohol grades. Risk increases when a manufacturer requires a highly specific grade, has only one qualified site, or operates under tight sustainability and animal-origin restrictions.

References

1. BASF SE. (2024). Annual report 2023. BASF.
2. Croda International Plc. (2024). Annual report and accounts 2023. Croda International.
3. KLK OLEO. (2024). Corporate and product information. KLK OLEO.
4. IOI Corporation Berhad. (2024). Annual report 2024. IOI Corporation.
5. U.S. Food and Drug Administration. (2024). Inactive ingredient database. FDA. https://www.accessdata.fda.gov/scripts/cder/iig/index.cfm
6. European Commission. (2024). CosIng: Cosmetic ingredients and substances. European Commission. https://single-market-economy.ec.europa.eu/sectors/cosmetics/cosmetic-ingredient-database_en